Rapid Sequence Intubation: Outcomes With Etomidate Versus Ketamine for Induction in Critically Ill Patients
Journal of Pharmacy and Bioallied Sciences · 2026-10 · 18 (4) · 399-401
DOI: 10.4103/jpbs.jpbs_200_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Bioallied Sciences, online erschienen am 17.11.2026. Verfasst von Rakesh Bhaisare und 2 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A BSTRACT Background: Selection of the induction agent during rapid sequence intubation (RSI) remains important because critically ill patients frequently have limited physiological reserve. This study compared clinical outcomes after etomidate versus ketamine induction for emergency tracheal intubation.
Methods
A prospective observational comparative study was conducted in the emergency department and intensive care unit of a tertiary hospital over 12 months. One hundred sixty adult critically ill patients undergoing RSI were allocated according to the induction agent used: etomidate 0.3 mg/kg ( n = 80) or ketamine 1.5 mg/kg ( n = 80), followed by succinylcholine or rocuronium. Primary outcome was postinduction hypotension within 15 minutes. Secondary outcomes were first-pass intubation success, peri-intubation hypoxemia, vasopressor requirement, intensive care unit length of stay, and 28-day mortality.
Results
Baseline age was comparable between etomidate and ketamine groups (56.8 ± 15.2 vs 55.1 ± 14.7 years; P = 0.46). Postinduction hypotension occurred in 17.5% of etomidate patients and 27.5% of ketamine patients ( P = 0.13). First-pass success was similar (88.8% vs 86.3%; P = 0.64). Vasopressor escalation was numerically lower with etomidate (20.0% vs 31.3%; P = 0.10), while 28-day mortality did not differ significantly (23.8% vs 26.3%; P = 0.72).
Conclusion
Etomidate and ketamine produced comparable intubation success and mortality. Etomidate showed a clinically relevant trend toward better immediate hemodynamic stability, whereas ketamine remained a reasonable alternative when analgesic and bronchodilatory properties were desirable.
Zitieren
APA
Bhaisare, R., Kothari, A., & Deshpande, H. (2026). Rapid Sequence Intubation: Outcomes With Etomidate Versus Ketamine for Induction in Critically Ill Patients. Journal of Pharmacy and Bioallied Sciences, 18(4), 399-401. https://doi.org/10.4103/jpbs.jpbs_200_26
Vancouver
Bhaisare R, Kothari A, Deshpande H. Rapid Sequence Intubation: Outcomes With Etomidate Versus Ketamine for Induction in Critically Ill Patients. Journal of Pharmacy and Bioallied Sciences. 2026;18(4):399-401. doi:10.4103/jpbs.jpbs_200_26
BibTeX
@article{Bhaisare2026,
author = {Bhaisare, Rakesh and Kothari, Amit and Deshpande, Hemant},
title = {Rapid Sequence Intubation: Outcomes With Etomidate Versus Ketamine for Induction in Critically Ill Patients},
journal = {Journal of Pharmacy and Bioallied Sciences},
year = {2026},
volume = {18},
number = {4},
pages = {399--401},
doi = {10.4103/jpbs.jpbs_200_26}
}
EUVIMED